Coagulation factor VIII levels are associated with long-term survival - Interactions with gender in a large hospital-based cohort

Wiener Klinische Wochenschrift

Volumn 122, Issue 11-12, 2010, Pages 334-340

  Kovar, Florian M ^a   Marsik, Claudia L ^a   Joukhadar, Christian ^b,c,d   Perkmann, Thomas ^a   Haslacher, Helmuth ^a   Schickbauer, Thomas ^a   Kyrle, Paul A ^a   Wagner, Oswald F ^a   Endler, Georg ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d J & P Medical Research Ltd   (Austria)

Author keywords

Arterial and venous thrombosis; FVIII; Gender related differences; Prevention

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SEX DIFFERENCE; SURVIVAL TIME;

ADULT; AGE FACTORS; AUSTRIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FACTOR VIII; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; RISK; SEX FACTORS; STATISTICS AS TOPIC; SURVIVAL RATE; THROMBOSIS;

EID: 77954620446     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-010-1386-1     Document Type: Article

References (27)

1. GM Bhopale RK Nanda 2003 Blood coagulation factor VIII: an overview J Biosci 28 783 789 10.1007/BF02708439 1:CAS:528:DC%2BD2cXktlWksQ%3D%3D 14660878
2. RM Bertina 2003 Elevated clotting factor levels and venous thrombosis Pathophysiol Haemost Thromb 33 395 400 10.1159/000083835 15692250 (Pubitemid 40278714)
3. M de Lange H Snieder RA Ariens TD Spector PJ Grant 2001 The genetics of haemostasis: a twin study Lancet 357 101 105 10.1016/S0140-6736(00)03541-8 1:CAS:528:DC%2BD3MXntlOqsg%3D%3D 11197396 (Pubitemid 32094912)
4. M Berger M Mattheisen B Kulle H Schmidt J Oldenburg H Bickeboller, et al. 2005 High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11 Blood 105 638 644 10.1182/blood-2004-05- 2018 1:CAS:528:DC%2BD2MXltlGgsw%3D%3D 15353485 (Pubitemid 40070747)
5. PW Kamphuisen JC Eikenboom HL Vos R Pablo A Sturk RM Bertina, et al. 1999 Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions Thromb Haemost 81 680 683 1:CAS:528:DyaK1MXjtFOguro%3D 10365736
6. T Koster AD Blann E Briet JP Vandenbroucke FR Rosendaal 1995 Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 152 155 10.1016/S0140-6736(95)90166-3 1:STN:280:DyaK2M7isVShsw%3D%3D 7823669
7. J O'Donnell M Laffan 2001 Elevated plasma factor VIII levels - a novel risk factor for venous thromboembolism Clin Lab 47 1 6 11214218
8. J O'Donnell AD Mumford RA Manning M Laffan 2000 Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response Thromb Haemost 83 10 13 10669146
9. PW Kamphuisen JC Eikenboom FR Rosendaal T Koster AD Blann HL Vos, et al. 2001 High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene Br J Haematol 115 156 158 10.1046/j.1365-2141.2001.03089.x 1:CAS:528:DC%2BD3MXotFWmtr8%3D 11722428 (Pubitemid 32995111)
10. R Vormittag P Bencur C Ay T Tengler T Vukovich P Quehenberger C Mannhalter I Pabinger 2007 Low density lipoprotein receptor related protein 1 polymorphism 663 C/T affects clotting factro VIII activity and increases the risk of venous thromboembolism J Thromb Haemost 5 497 502 10.1111/j.1538-7836. 2007.02337.x 1:CAS:528:DC%2BD2sXktFCju7g%3D 17155964 (Pubitemid 46680681)
11. PA Kyrle S Eichinger 2003 The risk of recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism Wien Klin Wochenschr 115 471 474 10.1007/BF03041030 13677265 (Pubitemid 37047475)
12. I Bank EJ Libourel S Middeldorp K Hamulyak EC van Pampus MM Koopman, et al. 2005 Elevated levels of FVIII: C within families are associated with an increased risk for venous and arterial thrombosis J Thromb Haemost 3 79 84 10.1111/j.1538-7836.2004.01033.x 1:CAS:528:DC%2BD2MXht12rtLw%3D 15634269 (Pubitemid 41647118)
13. L Gallinaro MG Cattini M Sztukowska R Padrini F Sartorello E Pontara A Bertomoro V Daidone A Pagana A Casonato 2008 A shorter von Willebrand factor survival in 0 blood group subjects explains how AB0 determines influence plasma von Willebrand factor Blood 111 3540 3545 10.1182/blood-2007-11-122945 1:CAS:528:DC%2BD1cXktlWmsLo%3D 18245665
14. J O'Donnell MA Laffan 2001 The relationship between AB0 histo-blood group, factor VIII and von Willebrand factor Transfus Med 11 343 351 10.1046/j.1365-3148.2001.00315.x 11532189 (Pubitemid 32771926)
15. I Martinelli D Girelli P Ferraresi O Olivieri B Lunghi F Manzato R Corrocher F Bernardi 2007 Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism Blood Coagul Fibrinolysis 18 125 129 10.1097/MBC.0b013e328011c06d 1:CAS:528:DC%2BD2sXhsVSisb8%3D 17287628 (Pubitemid 46232832)
16. GI Rice PJ Grant 1998 FVIII coagulant activity and antigen in subjects with ischaemic heart disease Thromb Haemost 80 757 762 1:CAS:528: DyaK1cXnsF2jur4%3D 9843167
17. AJ Catto AM Carter JH Barrett J Bamford PJ Rice PJ Grant 1997 von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality Thromb Haemost 77 1104 1108 1:CAS:528:DyaK2sXksFKlurs%3D 9241740
18. MJ Hollestelle HG Geertzen IH Straatsburg TM van Gulik JA van Mourik 2004 Factor VIII expression in liver disease Thromb Haemost 91 267 275 1:CAS:528:DC%2BD2cXhs1Sqtb0%3D 14961153
19. AR Folsom JA Delany PL Lutsey NA Zakai NS Jenny JF Polak M Cushman Multiethnic Study of Atherosclerosis Investigators 2009 Associations of Factor VIII, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality Am J Hematolog 84 349 353 10.1002/ajh.21429 1:CAS:528:DC%2BD1MXns1Sjtbw%3D
20. I Martinelli M Primignani A Aghemo R Reati P Bucciarelli F Fabris T Battaglioli A Dell'Era PM Mannucci 2009 High levels of factor VIII and risk for extra hepatic portal vein obstruction J Hepatology 50 916 922 10.1016/j.jhep.2008.12.020 1:CAS:528:DC%2BD1MXkslKksb0%3D
21. I Martinelli 2005 von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis Semin Hematol 42 49 55 10.1053/j. seminhematol.2004.09.009 1:CAS:528:DC%2BD2MXhsFaktLw%3D 15662616 (Pubitemid 40127270)
22. I Bank MH van de Poel M Coppens K Hamu'yak MH Prins J van der Meer NJ Veeger HR Büller S Middeldrop 2007 Absolute annual incidence of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII: C a prospective family cohort study Thromb Haemost 98 1040 1044 1:CAS:528:DC%2BD2sXhsVWrsbnI 18000609
23. MC de Visser FR Rosendaal RM Bertina 1999 A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis Blood 93 1271 1276 1:CAS:528:DyaK1MXht1Cjur4%3D 9949170
24. CM Henkens VJ Bom J van der Meer 1995 Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity Thromb Haemost 74 1198 1199 1:CAS:528:DyaK2MXptVyhsL8%3D 8560436
25. KM Brinkhous H Sandberg JB Garris C Mattsson M Palm T Griggs, et al. 1985 Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs Proc Natl Acad Sci USA 82 8752 8756 10.1073/pnas.82.24.8752 1:CAS:528: DyaL28Xms12jtg%3D%3D 3936044
26. AJ Vlot SJ Koppelman BN Bouma JJ Sixma 1998 Factor VIII and von Willebrand factor Thromb Haemost 79 456 465 1:CAS:528:DyaK1cXhs1Cju7k%3D 9531024
27. JC Souto L Almasy M Borrell M Gari E Martinez J Mateo, et al. 2000 Genetic determinants of hemostasis phenotypes in Spanish families Circulation 101 1546 1551 1:CAS:528:DC%2BD3cXivVyhtr8%3D 10747348